Therapeutic Advances in Medical Oncology
image
Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis

DOI: 10.1177/1758835920923431, Volume: 12, Pages: 0-0
Article Type: research-article, Article History
https://www.researchpad.co/tools/openurl?pubtype=&doi=10.1177/1758835920923431&title=Rationale and protocol design for the TORG1835/NEXT-SHIP study: a phase II study of carboplatin, etoposide and nintedanib for unresectable limited/extensive disease small cell lung cancer with idiopathic pulmonary fibrosis&author=&keyword=[{keywordId=262, uniqueName=etoposide, name=etoposide, contentId=18869}, {keywordId=2706, uniqueName=small-cell-lung-cancer, name=Small cell lung cancer, contentId=18869}, {keywordId=17320, uniqueName=idiopathic-pulmonary-fibrosis, name=idiopathic pulmonary fibrosis, contentId=18869}, {keywordId=21927, uniqueName=carboplatin, name=carboplatin, contentId=18869}, {keywordId=27750, uniqueName=nintedanib, last=true, name=nintedanib, contentId=18869}],[{keywordId=262, uniqueName=etoposide, name=etoposide, contentId=18869}, {keywordId=2706, uniqueName=small-cell-lung-cancer, name=Small cell lung cancer, contentId=18869}, {keywordId=17320, uniqueName=idiopathic-pulmonary-fibrosis, name=idiopathic pulmonary fibrosis, contentId=18869}, {keywordId=21927, uniqueName=carboplatin, name=carboplatin, contentId=18869}, {keywordId=27750, uniqueName=nintedanib, last=true, name=nintedanib, contentId=18869}],[{keywordId=262, uniqueName=etoposide, name=etoposide, contentId=18869}, {keywordId=2706, uniqueName=small-cell-lung-cancer, name=Small cell lung cancer, contentId=18869}, {keywordId=17320, uniqueName=idiopathic-pulmonary-fibrosis, name=idiopathic pulmonary fibrosis, contentId=18869}, {keywordId=21927, uniqueName=carboplatin, name=carboplatin, contentId=18869}, {keywordId=27750, uniqueName=nintedanib, last=true, name=nintedanib, contentId=18869}],[{keywordId=262, uniqueName=etoposide, name=etoposide, contentId=18869}, {keywordId=2706, uniqueName=small-cell-lung-cancer, name=Small cell lung cancer, contentId=18869}, {keywordId=17320, uniqueName=idiopathic-pulmonary-fibrosis, name=idiopathic pulmonary fibrosis, contentId=18869}, {keywordId=21927, uniqueName=carboplatin, name=carboplatin, contentId=18869}, {keywordId=27750, uniqueName=nintedanib, last=true, name=nintedanib, contentId=18869}],[{keywordId=262, uniqueName=etoposide, name=etoposide, contentId=18869}, {keywordId=2706, uniqueName=small-cell-lung-cancer, name=Small cell lung cancer, contentId=18869}, {keywordId=17320, uniqueName=idiopathic-pulmonary-fibrosis, name=idiopathic pulmonary fibrosis, contentId=18869}, {keywordId=21927, uniqueName=carboplatin, name=carboplatin, contentId=18869}, {keywordId=27750, uniqueName=nintedanib, last=true, name=nintedanib, contentId=18869}],&subject=